ArticleJGH open : an open access journal of gastroenterology and hepatology2023

Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma.

Yoshihiko Yano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.